Federal District Court Judge Hon. David R. Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) pay $1 million in sanctions for discovery abuses in the multidistrict litigation (MDL) involving the oral anticoagulant Predaxa. This same U.S. Federal District Court, also in the Southern District of Illinois, is where many of the country’s Yasmin and YAZ (Drospirenone) birth control injury cases are being handled; also in an MDL.
Judge Herndon found that BIPI, the maker of Predaxa, had chosen not to produce thousands of documents to the plaintiffs, which the judge determined was bad-faith conduct.
According to the order, BIPI and its German parent company were unable to explain why it chose not to produce critical documents and communications by a deadline set by the judge. The deadline was in June 2012.